Redirected T cells thereby target CLL cells in an MHC-unrestricted fashion, secret proinflammatory cytokines, and eliminate CD19+ leukaemia cells with high efficiency. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.